EMULATE THERAPEUTICS, INC.

Profile

Company Names

EMULATE THERAPEUTICS, INC.
NATIVIS, INC.

Addresses

425 PONTIUS AVENUE NORTH SUITE 200, SEATTLE, WA 98109

425 PONTIUS AVENUE NORTH, SUITE 200, SEATTLE, WA 98109

219 TERRY AVENUE NORTH, SUITE 200, SEATTLE, WA 98109

219 TERRY AVENUE NORTH, SUITE 200, SEATTLE, WA 98109

11975 NORTH TORREY PINES ROAD, SUITE 150, LA JOLLA, CA 92037

Phone Numbers

(206) 708-2288
(858) 643-5500

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER TECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

WASHINGTON

Total Amount Raised:

$26,902,270.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2019-09-06 
$450,000.00 
$5,000,000.00 
$4,550,000.00 
Debt 
6
2017-11-06 
$4,117,760.00 
$10,000,000.00 
$5,882,240.00 
Equity 
5
2017-05-05 
$210,000.00 
$5,000,000.00 
$4,790,000.00 
Debt 
4
2015-12-14 
$9,618,795.00 
$50,000,000.00 
$40,381,205.00 
Equity 
3
2015-06-09 
$725,000.00 
$10,000,000.00 
$9,275,000.00 
Equity 
2
2012-02-28 
$11,480,715.00 
$18,000,000.00 
$6,519,285.00 
Equity 
1
2010-04-07 
$300,000.00 
$7,500,000.00 
$7,200,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BENNETT 
BUTTERS 
DIRECTOR
BENNETT 
M. 
BUTTERS 
DIRECTOR
JOHN 
BUTTERS 
EXECUTIVE OFFICER, DIRECTOR
JOHN 
T. 
BUTTERS 
EXECUTIVE OFFICER, DIRECTOR
LISA 
BUTTERS 
DIRECTOR
LISA 
C. 
BUTTERS 
EXECUTIVE OFFICER, DIRECTOR
ANDY 
 
DANIELS 
DIRECTOR
CLARK 
DONNELL 
DIRECTOR
CLARK 
W. 
DONNELL 
DIRECTOR
DAVE 
 
GRIEGER 
DIRECTOR
DAVID 
 
GRIEGER 
DIRECTOR
DICK 
 
HENRIQUES 
DIRECTOR
SEAN 
 
KELL 
DIRECTOR
JOHN 
 
KINGMA 
DIRECTOR
JOHN 
KINGMA 
DIRECTOR
JOHN 
KINGMA 
DIRECTOR
JOHN 
E. 
KINGMA 
EXECUTIVE OFFICER, DIRECTOR
DANIEL 
 
KISNER 
DIRECTOR
CHARLES 
 
MCNERNEY 
DIRECTOR
NANCY 
 
NORDHOFF 
DIRECTOR
NANCY 
NORDHOFF 
DIRECTOR
NANCY 
S. 
NORDHOFF 
DIRECTOR
JOHN 
PAYNE 
DIRECTOR
STEVEN 
POPE 
EXECUTIVE OFFICER
CHRIS 
 
RIVERA 
EXECUTIVE OFFICER, DIRECTOR
MICHAEL 
K. 
ULLMAN 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-09-06 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-06 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-06 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-05-05 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-09 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-02-28 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-02-28 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#